Turnaround Q2 result lifts Shasun Chemicals & Drugs

News Flash

FOREIGN FUNDS NET SELL RS.463.89 CR IN EQUITIES ON NOVEMBER 20 (PROV)
MUTUAL FUNDS NET SELL RS.176.7 CR IN EQUITIES ON NOVEMBER 19
DII'S NET BUY RS.18.46 CR IN EQUITIES ON NOVEMBER 20 (PROV)
TO ENTER INTO CUSTOMIZED MOTOR CYCLE BIZ VIA PRO-BIKING SHOWROOMS
TO EXPAND PANTNAGAR CAPACITY TO 70,000 UNITS IN NEXT FEW MONTHS
AKER IS A NORWEGIAN SERVICE PROVIDER CO FOR OIL AND GAS OPERATIONS
AKER SOLUTIONS TO PROVIDE SUPPORT SERVICES IN KG BASIN
AKER BAGGED SUB SEA PRODUCTION ORDER FROM RIL IN 2006 ALSO
RELIANCE IND PLACES RS.115 CR ORDER WITH NORWAY'S AKER SOLUTIONS
PORTING CHARGES TO BECOME APPLICABLE FROM DECEMBER 31, 2009
MNP ALLOWS USERS TO CHANGE OPERATORS WHILE RETAINING MOBILE NOS
USERS TO PAY MAX OF RS.19 TO CHANGE OPERATOR WHILE RETAINING OLD NUMBER
TRAI COMES OUT WITH NUMBER PORTABILITY CHARGES
PUNJAB NATIONAL BANK PLANS TO RAISE RS 700 CR BY SELLING BONDS
TATA TELE-QUIPPO OFFERING BETTER SERVICING DEAL FOR TOWERS: SOURCES
GTL BID 10-15% HIGHER THAN TATA-QUIPPO: SOURCES
DEAL VALUED AT AROUND RS.6000 CR : SOURCES
MAY JOIN RACE FOR SHELL'S EUROPEAN REFINERIES: SOURCES
SENSEX, NIFTY UP 1% EACH FOR THE WEEK
CNX MIDCAP INDEX UP 1%, BSE SMALLCAP INDEX UP 1.6%
METAL INDEX UP 3.7%, AUTO INDEX UP 2.3%, FMCG UP 1.5%
INDEX GAINERS: SUZLON UP 9.3%, TATA STEEL UP 6.3%, SAIL UP 5.3%
APPROACHED SHELL FOR BUYOUTS BEFORE ESSAR'S EXCLUSIVE TALKS BEGUN
ESSAR-SHELL IN EXCLUSIVE NEGOTIATIONS TILL NOV 30 TO BUY 3 SHELL REFINERIES
RIL SPOKESPERSON: 'WE ARE REVIEWING A NUMBER OF GLOBAL OPPORTUNITIES'
RIL SPOKESPERSON TO NDTV: 'REVIEWS CANNOT ASSURE TRANSACTIONS'
JSW ENERGY ALSO IN RACE FOR ANDREW YULE'S DPSC STAKE: NW
CESC, SREI INFRA IN RACE FOR ANDREW YULE'S DPSC STAKE: NW
GAMMON INFRA BAGS NHAI PROJECT WORTH RS.850 CRORES
NET PROFIT AT RS.48.2 CR VS RS.12 CR; SALES UP 55% AT RS.849 CR (YOY)

Updated: 30/10/2009 | 12:00 AM IST

Hot pursuit

Capital Market

Friday, October 30, 2009 (New Delhi)

Blog

Comments:

Read (0)

Post

Rate the story

Meanwhile, the BSE Sensex was up 98.96 points, or 0.62%, to 16,151.68.

On BSE, 22,494 shares were traded in the counter as against an average daily volume of 93,366 shares in the past one quarter.

The stock hit a high of Rs 32.45 and a low of Rs 32.30 so far during the day. The stock had hit a 52-week high of Rs 39.50 on 23 October 2009 and a 52-week low of Rs 10.55 on 2 December 2008.

Ahead of Q2 September 2009 results, the stock had slumped 17.80% in five trading sessions to Rs 30.95 on 29 October 2009 from a recent high of Rs 37.65 on 22 October 2009.

The small-cap stock had underperformed the market over the past one month till 29 October 2009, falling 7.47% as compared to the Sensex's 4.75% fall. It had outperformed the market in the past one quarter, gaining 36.64% as compared to the Sensex's return of 5.79%.

The company's equity capital is Rs 9.66 crore. Face value per share is Rs 2.

The current price of Rs 32.45 discounts the company's Q2 September 2009 annualized EPS of Rs 1.49, by a PE multiple of 21.78.

Shasun Chemicals & Drugs' net sales fell 11% to Rs 184.78 crore in Q2 September 2009 over Q2 September 2008. On a standalone basis, the company posted net profit of Rs 1.80 crore in Q2 September 2009 as against net loss of Rs 10.71 crore in Q2 September 2009. Total income rose 5% to Rs 128.82 crore in Q2 September 2009 over Q2 September 2008. The company declared its results after trading hours on Thursday, 29 October 2009.

The company achieved a turnaround-consolidated numbers, due to Rs 16.71 crore profit earned from sales of discontinued operations.

During the quarter ended September 2009, the company incurred a foreign exchange loss of Rs 7.29 crore.

The company is engaged in the manufacture of active pharmaceutical ingredients (API) and drug products with a significant presence in the anti-inflammatory and anti-ulcerative therapeutic groups.

Powered by Capital Market - Live News